Seven years&rsquo; experience with alendronate in postmenopausal Japanese women with osteoporosis

Seven years&rsquo; experience with alendronate in postmenopausal Japanese women with osteoporosis

Jun Iwamoto1, Yoshihiro Sato2, Mitsuyoshi Uzawa3, Tsuyoshi Takeda1, Hideo Matsumoto11Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan; 2Department of Neurology, Mitate Hospital, Fukuoka, Japan; 3Department of Orthopaedic Surgery, Keiyu Orthopaedic Hospital,...

Full description

Bibliographic Details
Main Authors:	Jun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2010-04-01
Series:	Therapeutics and Clinical Risk Management
Online Access:	http://www.dovepress.com/seven-yearsrsquo-experience-with-alendronate-in-postmenopausal-japanes-a4297

Similar Items

Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone&nbsp;turnover in postmenopausal women with osteoporosis
by: Jun Iwamoto, et al.
Published: (2009-07-01)

Five-year alendronate treatment outcome in older postmenopausal Japanese women with osteoporosis or osteopenia and clinical risk factors for fractures
by: Jun Iwamoto, et al.
Published: (2009-09-01)

Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature
by: Jun Iwamoto, et al.
Published: (2008-09-01)

Alendronate improves QOL of postmenopausal women with osteoporosis
by: Hisaya Kawate, et al.
Published: (2010-04-01)

Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures [Expression of concern]
by: Iwamoto J, et al.
Published: (2018-10-01)

Seven years&rsquo; experience with etidronate in a woman with anorexia nervosa and vertebral fractures
by: Iwamoto J, et al.
Published: (2011-07-01)

Influence of treatment with alendronate on the speed of sound, an ultrasound parameter, of the calcaneus in postmenopausal Japanese women with osteoporosis: a clinical practice-based observational study
by: Iwamoto J, et al.
Published: (2012-06-01)

A Radiographic Study on the Associations of Age and Prevalence of Vertebral Fractures with Abdominal Aortic Calcification in Japanese Postmenopausal Women and Men
by: Jun Iwamoto, et al.
Published: (2010-01-01)

Two Years of Alendronate and Calcitonin Treatments for Osteoporosis in Postmenopausal Women - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)

Three-year experience with combined treatment with alendronate and alfacalcidol in Japanese patients with severe bone loss and osteoporotic fracture
by: Iwamoto J, et al.
Published: (2011-06-01)

Evaluation of bone remodelling parameters after one year treatment with alendronate in postmenopausal women with osteoporosis
by: Elma Kučukalić-Selimović, et al.
Published: (2011-02-01)

The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis
by: S. Akı, et al.
Published: (2002-03-01)

The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis
by: İlker Çorapçı, et al.
Published: (2004-03-01)

Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
by: Kurtuluş Kaya, et al.
Published: (2009-12-01)

The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)

Effects of Alendronate, Calcitonin and Raloxifene Used in the Treatment of Postmenopausal Osteoporosis On Serum No Levels
by: Saliha Karatay, et al.
Published: (2005-03-01)

Cost effectiveness of alendronate to reduce hip fractures from osteoporosis in Icelandic postmenopausal women
by: Hauksson, Gudjon
Published: (2018)

The Effect of Alendronate and Calcitonin Treatments on Bone Mineral Density and Quality of Life in Women With Postmenopausal Osteoporosis
by: F. Taşçıoğlu, et al.
Published: (2002-06-01)

Vitamin D Boosts Alendronate Tail Effect on Bone Mineral Density in Postmenopausal Women with Osteoporosis
by: Antonino Catalano, et al.
Published: (2021-05-01)

Use of alendronate in the therapy of osteoporosis
by: O. B. Ershova
Published: (2020-01-01)

The Effect of Alendronate in Male Osteoporosis
by: Özlem El, et al.
Published: (2004-12-01)

Vitamin K2 Therapy for Postmenopausal Osteoporosis
by: Jun Iwamoto
Published: (2014-05-01)

Economic Evaluation of Oral Alendronate Therapy for Osteoporosis in Chinese Postmenopausal Women: The Impact of Medication Compliance and Persistence
by: Ruxu You, et al.
Published: (2020-11-01)

Effect of Alendronate Treatment on Salivary Levels of Osteoprotegrin and TNF-α in Postmenopausal Woman with Osteoporosis and Periodontal Diseases
by: Aseel J. Ibraheem, et al.
Published: (2018-06-01)

Alendronate versus Raloxifene for Postmenopausal Women: A Meta-Analysis of Seven Head-to-Head Randomized Controlled Trials
by: Tiao Lin, et al.
Published: (2014-01-01)

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis
by: M Stevenson, et al.
Published: (2005-06-01)

Patients&rsquo; and caregivers&rsquo; experiences of the impact of Parkinson&rsquo;s disease on health status
by: Horacio Chiong-Rivero, et al.
Published: (2011-03-01)

Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis
by: Fatemeh Khanizadeh, et al.

Effect of Vitamin K and Alendronate Combination Treatment on Bone Mineral Density of Postmenopausal Osteoporosis Patients: A Pilot Study
by: Mohammad Hassan Jokar, et al.
Published: (2016-01-01)

Five-year follow-up of a woman with pregnancy and lactation-associated osteoporosis and vertebral fractures
by: Sato Y, et al.
Published: (2012-04-01)

Efficacy of generic alendronate and ibandronate in post menopausal osteoporosis
by: NP Somasundaram, et al.
Published: (2012-03-01)

The Comparison of Effects of Alendronate and Calcitonin Treatment in Men With Osteoporosis
by: Gülcan Gürer, et al.
Published: (2004-09-01)

Efficacy and safety of alendronic acid in the treatment of osteoporosis in children
by: Alberto Martín Siguero, et al.
Published: (2015-11-01)

Combined Use of Ibandronate and Eldecalcitol in Postmenopausal Japanese Women with Osteoporosis
by: Junichi Takada, et al.
Published: (2016-12-01)

Efficacy, safety, and compliance of ibandronate treatment for 3 years in postmenopausal Japanese women with primary osteoporosis
by: Takako Suzuki, et al.
Published: (2018-06-01)

Effects of 3-year denosumab treatment on hip structure in Japanese postmenopausal women and men with osteoporosis
by: Teruki Sone, et al.
Published: (2017-12-01)

Treatment of postmenopausal osteoporosis, patient perspectives &ndash; focus on once yearly zoledronic acid
by: Raj Carmona, et al.
Published: (2009-07-01)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
by: Fujiwara S, et al.
Published: (2014-11-01)

Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis
by: Yeesuk Kim, et al.
Published: (2020-07-01)

The carcinogenicity of alendronate in patients with osteoporosis: evidence from cohort studies.
by: Ling-Xiao Chen, et al.
Published: (2015-01-01)